|
Impact Investing is a growing movement that seeks to drive a measurable social impact with the expectation of a return on capital. Our passion is preserving and restoring vision by investing in innovative treatments, diagnostics, and vision aids in order to maximize the human potential of those afflicted with eye disease and injury. We have brought together a passionate team of professionals who are highly motivated to make an impact, whether they are personally affected by vision loss, are ophthalmologists, and/or want to invest in a cause about which they care deeply. Our collective impact is to improve the lives of the visually impaired and achieve financial returns by investing our time, capital and considerable expertise in early stage eye care companies.
To learn more or become involved,, please contact us. |
"THIS MEDICAL CHARITY MADE $3.3 BILLION FROM A SINGLE PILL" |
Industry Updates
Eyes on the Horizon: The Impact Investor Survey
Eyes on the Horizon, the 2015 edition of the GIIN and J.P. Morgan annual impact investor survey, reveals a growing global market, with impact investments being made across all geographies and a range of sectors. In its fifth year, the survey continues to provide detailed insight into a number of key market variables such as the types of investors, the number and size of investments made and targeted, as well as reported risk and use of loss protection. Download the full report > |
This Medical Charity Made $3.3 Billion From a Single Pill
How the Cystic Fibrosis Foundation amassed a fortune—and upended medical research at the same time. Read more at Bloomberg.com |
Impact Investing Guides
We encourage you to learn more about impact investing from these thought leaders and the materials they have assembled.
The Case FoundationA Short Guide to Impact Investing: A PRIMER ON HOW BUSINESS CAN DRIVE SOCIAL CHANGE.
|
GIINThe Global Impact Investing Network (GIIN) is a nonprofit organization dedicated to increasing the effectiveness of impact investing.
|
Venture PhilanthropyHighlights from a Healthcare Venture Philanthropy Summit sponsored by Broadview Ventures with key-takeaways from the meeting as well as survey results from participants.
|